Activation of Akt as a Mechanism for Tumor Immune Evasion
Open Access
- 1 March 2009
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 17 (3), 439-447
- https://doi.org/10.1038/mt.2008.255
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Targeting AKT Signaling Sensitizes Cancer to Cellular ImmunotherapyCancer Research, 2008
- The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune EvasionCancer Research, 2007
- Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune EvasionCancer Research, 2007
- Increased expression of pAKT is associated with radiation resistance in cervical cancerBritish Journal of Cancer, 2006
- Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitopeGene Therapy, 2005
- Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing AktCancer Research, 2004
- Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase productionThe FASEB Journal, 2001
- Cyclic AMP Inhibits Akt Activity by Blocking the Membrane Localization of PDK1Published by Elsevier BV ,2001
- Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunityGene Therapy, 2000
- Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 TranslocationJournal of Biological Chemistry, 1996